Agenda
Bill C-9, An Act to amend the Patent Act and the Food and Drugs ActBill C-9, An Act to amend the Patent Act and the Food and Drugs Act. Appearing
(3:00 PM)
The Honourable Bill Graham, P.C., MP,
Minister of Foreign Affairs
(3:30 PM)
The Honourable Lucienne Robillard, P.C., MP,
Minister of Industry
Witnesses
Industry Canada:- Susan Bincoletto, Acting Director General - Marketplace Framework Policy Branch
- Éric Dagenais, Director - Patent Policy Directorate
- Doug Clark, Senior Project Leader - Patent Policy Directorate
- Rob Sutherland-Brown, Senior Counsel - Industry Canada Legal Services
Health Canada:- Dr. Robert Peterson, Director General, Therapeutic Products Directorate, Health Products and Food Branch
- David K. Lee, Director, Office of Patented Medicines and Liaison, Therapeutic Products Directorate, Health Products and Food Branch
Canadian International Development Agency:- Sandra Black, Director, Social Development Policies, Policy Branch
Canada's Research-Based Pharmaceutical Companies:- Jean-François Leprince, President, Aventis Pharmaceutical, Chair, Rx&D Intellectual Property Committee
- Terry McCool, Vice-President, Corporate Affairs, Eli Lilly Canada Inc., Vice-Chair, Rx&D Intellectual Property Committee
- Adrienne Blanchard, Legal Counsel, Gowlings, Lafleur and Henderson
Canadian Generic Pharmaceutical Association:- Jim Keon, President
Clause-by-clause consideration of Bill C-9
Meeting with Reporting and Interpretation